A Study to Investigate JNJ-40411813 in Combination With Levetiracetam in Epilepsy
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of up to 3 dose levels of adjunctive
JNJ-40411813 compared to placebo based on the time to baseline monthly seizure count in
participants with focal onset seizures who are receiving levetiracetam and up to 3 other
anti-epileptic drugs (AEDs).